We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Current market cap around £4 Million,they will have around £8 Million in the bank when deal is done & dusted. It will be a new company with assets of the company there taking over. So stand to reason they will be worth more. They has a fund rasing that was %400 over subscribed. Don't think even royal mail did that well.
The low price was only made available to shareholders before the announcement regarding Premaitha being taken over by Vialogy and becoming that business in July, so all those who are now interested in having a stake in Premaitha have to buy on the open market, and the offer was one new share per 400 old shares already held, so not many were available in the first place. The free float after consolidation is estimated at around 10% only as most of the shares are tied up with the directors and institutions who took part in the subscription, which was 4 times oversubscribed.
Hi All, I hold a small holding here but I am interested in the views of people. There will be a placement of 95 Million shares on the 3rd July at .11 or 11p (after consolidation). Surely this will drive the price down to this level? Is this not the case? If not, why not? This is not a deramp. Quite the contrary. I want to top up, but looking at the best price I can buy in for of course.
And the deal has still not been cast in concrete yet. As Riddler said, relax, this really is not a trader stock, its not a recovery stock, its a brand new enterprise with sound credentials but with 3 top chaps after a slice of 4billion, give them time and buy now if you want a holding them put them away for 2 years. My advice would also be sell them if it slumps to. 7p. A worthwhile addition to a balanced portfolio.
where's Larry W. though? Lifetime ban for live prices, they could ban hundreds of posters. Nice one Mr.R
post consolidation, and when the product is fully operational then the sky's the limit as other products also start to come onboard, IONA is just the first one and it's ready to roll.
Did u manage to speak to him in the end?
thanks, think its a paid subscription site. all helps put it on the radar.
Not sure if you have to sign up to view the original link. You can even message BMD if you become a member. He calls me moaning gecko. http://guerillainvesting.co.uk/2014/06/26/vialogy-im-in-for-a-spin/
As a general rule of thumb we here at the world’s most infamous, libellous blog don’t usually cover stocks outside of the oil & gas/mining sectors. So it should be a surprise to learn that after slating SOFTWARE & COMPUTER SERVICES AIM listed Vialogy (VIY) shares when the “other lot” were in charge we are now or should I say ‘I have now increased my original token holding” and here’s why. The new improved Vialogy came back from restructuring/suspension a far healthier body politick, the tumour that was killing the Company has been excised. There is new life and where’s there’s life there is hope. Especially when Institutions have piled in en-mass because the new ‘cheeky chappies’ in charge have done exactly what they’ve promised to do here, before, a turnaround, making money for share-holders. The company rescuers are Adam Reynolds, David Evans and Stephen Little from Premaitha. A well-respected triumvirate! Suggest those that are looking for a quick spin. Do their sums. The recent £6.5 million placing at 0.11p. was FOUR TIMES oversubscribed with a raft of institutions now on board. I never took part in that placing because I was too busy with other matters and no one approached me! But I have bought in at a significantly higher price. “Vialogy has conditionally acquired the entire issued share capital of Premaitha, which is a molecular diagnostic company. The consideration of £10.5 million is to be satisfied by the issue of 95,454,545 New Ordinary Shares at a price of 11 pence per share. The Company has raised £6.5 million (before expenses) by means of the Placing and intends to raise up to a further £0.7 million by means of the Open Offer. The net proceeds of the Placing and the Open Offer will be used to develop and commercialize the IONA® Test, a non-invasive pre-natal screening test for Down’s Syndrome developed by Premaitha, and for general working capital purposes. The Acquisition, if completed, is of sufficient size to constitute a reverse takeover under the AIM Rules and therefore is subject to the approval of shareholders at a General Meeting to be held at 11.00 a.m. on 3 July 2014 at the offices of Panmure Gordon (UK) Limited, One New Change, London EC4M 9AF” Premaitha are working on the final development and commercialisation of a non-invasive pre-natal screening test for Down’s syndrome developed by Premaitha. The market for this is very, very large. $4.2 billion. Once the consolidation and proposals go through basically a foregone conclusion Vialogy will have £8,000,000 million in cash. In order for Adam Reynolds to take his options package at 0.1p or 10p post consolidation Vialogy would have to have been trading at above 0.5p or 50p post consolidation for 30 consecutive days. That speaks volumes to me. If Reynolds believes he can do this then I know that the Board are rolling their
No links sorry, just emails
BrokcermanDaniel tipped the share a few days before. Huge potential here. They where %400 oversubscribed on a recent fund raising.
thanks, i did wonder and started looking on twitter. any links?
Thats due to VIY being tipped by Hot Stock Rockets since 11am today
rush of volume last 30 mins and 15% up.
and 0.19 to sell, they want the shares!
Im already in profit after one day,great place to be. Volume is going up allot. Now is time to buy before this goes ballistic.
Nominal value means nothing,its the market value that counts.
They are tradable, in my account i could sell them at the current sale price :/
They are only worth 11p nominal value at they are no yet tradeable. Once they are tradeable they will be worth whatever the bid price is at that time
It better be sorted or else #@-*£?!_#@# will hit the fans across the country.
I just checked my halifax this morning, and the oo shares i requested are in my account, however it seesms they are only worth .11p each :/ and i paid 11p each for them, will this all be sorted out by friday? Si
Unlikely to change price of the Harmony ptoduct/service, most likely change froma slow US service that costs a lot more to a UK based company where the margins are much higher and the test is done in London. From here to January the potential will come clear.
will try and put something more cohesive together but doing research last night. is it a coincidence that we announce our new direction just after the RAPID study is concluded? The summary of the study is that its cost neutral at present - however, as this is important, its based solely on DS not the combined tests we can do in one hit. And its cost neutral based on a whopping £500 !!!! We smash that price - ergo I can see this being at standard early stage test across the spectrum for pregnancies
.17P buyer.looking good for next push up today.